We are a biotech company founded in London in 2024, with lymphatic regeneration technology backed by 15+ years of research and 6 international patents. We aim to enhance fertility in livestock, such as cows, by regenerating lymphatic vessels in the endometrium. Typically, cows become infertile by around 6 years of age and are slaughtered, but we aim to extend their productive lifespan by approximately two years, significantly improving calf production.

We have completed lab-scale production of a reagent capable of regenerating lymphatic vessels and are transitioning to pilot-scale production for POC and safety trials on infertile cows. Discussions are already underway with CDMO partners for mass production and farms for administering the treatment. We are currently seeking £250,000 in funding.

This technology also has environmental benefits, as reducing the number of cows can help lower greenhouse gas emissions and contribute to improved carbon credit outcomes.